Compounds > caffeic acid phenethyl ester
Page last updated: 2024-09-02

caffeic acid phenethyl ester and MPTP Neurotoxicity Syndrome

caffeic acid phenethyl ester has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dodel, RC; Du, Y; Farlow, MR; Fontanilla, CV; Klotsche, J; Ma, Z; Oertel, WH; Wei, X; Wisniowski, P; Zhao, L1

Other Studies

1 other study(ies) available for caffeic acid phenethyl ester and MPTP Neurotoxicity Syndrome

ArticleYear
Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration.
    Neuroscience, 2011, Aug-11, Volume: 188

    Topics: Animals; Blotting, Western; Brain; Caffeic Acids; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Phenylethyl Alcohol

2011